ACTU
ACTUATE THERAPEUTICS, INC.
Key Financials
Operating Income
$-22495312
↑ 10.6%
EPS (Diluted)
$-1.06
↑ 67.5%
Total Assets
$14.0M
↑ 50.6%
Net Income
$-22227852
↑ 18.5%
Shareholders' Equity
$7.9M
↑ 7505.6%
Total Liabilities
$6.1M
↓ 33.7%
Cash & Equivalents
$13.2M
↑ 52.3%
Operating Cash Flow
$-19206253.00
↑ 12.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| S-8 | 5/14/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACTU |
| Company Name | ACTUATE THERAPEUTICS, INC. |
| CIK | 1652935 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 847-986-4190 |